6.14
クリアランスは、血漿や腎臓や肝臓などの灌流度の高い臓器を含む中心コンパートメントからの薬物の排出を測定します。その計算は、薬物動態モデルと投与経路によって異なります。たとえば、1 コンパートメントモデルは、静脈内投与され尿中に容易に排泄されるアミノグリコシド系抗生物質などの極性薬物の薬物動態を表しま…
クリアランスは、血漿と腎臓や肝臓などの高度に灌流された臓器で構成される中央コンパートメントからの薬物排出を直接測定します。
クリアランスの計算は、薬物動態モデルと投与経路によって異なります。.
1コンパートメントモデルは、アミノグリコシド系抗生物質などの極性薬物の薬物動態を、静脈内投与され、尿中に容易に排泄される様子を説明しています。
ここで、ターミナルレート定数、λz、および分布の総体積の積であるVSssはクリアランスを与えます。
経口薬の吸収が排泄よりも速い場合、終末速度定数は排泄を表します。しかし、フリップフロップ現象では、経口吸収が排泄よりも遅い場合、速度定数は代わりに吸収を反映します。
2コンパートメントモデルは、血液灌流が不十分なコンパートメントに分布する極性の低い薬物の薬物動態を正確に表しています。臨床的には、抗生物質バンコマイシンの薬物動態は、このモデルによって効果的に予測されます。
特に、分布クリアランスは、血漿や灌流の良い臓器を含む中央の臓器と、灌流の少ない臓器を収容する末梢の2つのコンパートメント間のクリアランスを反映しています。
View the full transcript and gain access to JoVE Core videos
Q1: What does clearance measure in pharmacokinetics?
Clearance directly measures drug elimination from the central compartment, which comprises plasma and highly perfused organs like kidneys and liver. It quantifies how efficiently the body removes a drug and is essential for determining appropriate dosing regimens to maintain therapeutic drug levels while minimizing potential side effects.
Q2: How does the one-compartment model calculate drug clearance?
In the one-compartment model, clearance is calculated as the product of the terminal rate constant (λz) and total volume of distribution (Vss). This model effectively describes polar drugs like aminoglycoside antibiotics administered intravenously and readily excreted in urine, making it ideal for drugs with rapid, uniform distribution.
Q3: What is the flip-flop phenomenon in oral drug pharmacokinetics?
The flip-flop phenomenon occurs when oral drug absorption is slower than elimination. In this case, the terminal rate constant reflects absorption kinetics rather than elimination kinetics, potentially altering clearance calculations and requiring careful interpretation of pharmacokinetic parameters for accurate dosing.
Q4: Why is the two-compartment model used for less polar drugs?
The two-compartment model accurately represents pharmacokinetics of less polar drugs that distribute into poorly blood-perfused compartments. Vancomycin, a clinically important antibiotic, is effectively predicted by this model because it accounts for both central and peripheral compartment distribution, providing more accurate clearance predictions.
Q5: What is distributional clearance and how does it differ from total clearance?
Distributional clearance reflects drug movement between two compartments: the central compartment including plasma and well-perfused organs, and the peripheral compartment housing less-perfused organs. Unlike total clearance, which measures elimination from the body, distributional clearance describes the rate of drug redistribution between tissue compartments.
Q6: How does administration route affect clearance calculations in compartment models?
Clearance calculations vary depending on the administration route and pharmacokinetic model used. Intravenous administration with the one-compartment model provides straightforward clearance from the product of terminal rate constant and volume of distribution, while oral administration requires consideration of absorption kinetics and potential flip-flop phenomena.
Q7: What organs comprise the central compartment in clearance models?
The central compartment includes plasma and highly perfused organs such as kidneys and liver. These organs receive rapid blood flow and are where most drug elimination occurs, making them critical for understanding how clearance directly measures drug removal from this compartment.